Seeing Is Believing
Currently out of the existing stock ratings of Kevin Heal, 48 are a BUY (82.76%), 10 are a HOLD (17.24%).
Analyst Kevin Heal, currently employed carries an average stock price target met ratio of 70.83% that have a potential upside of 21% achieved within 334 days. Previously, Kevin Heal worked at ARGUS.
Kevin Heal’s has documented 109 price targets and ratings displayed on 18 stocks. The coverage was on the Financial Services sector.
Most recent stock forecast was given on CMA, Comerica at 29-Jan-2024.
Analyst best performing recommendations are on CMA (COMERICA).
The best stock recommendation documented was for CMA (COMERICA) at 10/30/2023. The price target of $52 was fulfilled within 44 days with a profit of $13.82 (36.2%) receiving and performance score of 8.23.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$11
$1.26 (12.94%)
$10
3 months 8 days ago
(16-Aug-2024)
3/15 (20%)
$0.9 (8.91%)
285
Buy
$10.25
$0.51 (5.24%)
$10
3 months 30 days ago
(25-Jul-2024)
4/9 (44.44%)
$0.38 (3.85%)
66
Buy
$11
$1.26 (12.94%)
$10.25
4 months ago
(24-Jul-2024)
1/4 (25%)
$1.06 (10.66%)
143
Buy
$12
4 months ago
(24-Jul-2024)
0/4 (0%)
$2.36 (24.48%)
Buy
$10
$0.26 (2.67%)
$10
4 months 8 days ago
(16-Jul-2024)
4/9 (44.44%)
$-0.51 (-4.85%)
147
What Year was the first public recommendation made by Kevin Heal?